Quantcast

Latest NanoSmart Pharmaceuticals Inc. Stories

2014-04-17 16:26:55

LAGUNA HILLS, Calif., April 17, 2014 /PRNewswire/ -- NanoSmart(®) and NanoValent, private pharmaceutical companies developing novel cancer pharmaceuticals, have entered into a research collaboration agreement to explore the feasibility of jointly developing an ANA-conjugated liposomal doxorubicin nanoparticle for the treatment of ovarian cancer and other solid tumors. The joint project combines NanoValent's hybrid polymerized liposomal nanoparticle (HPLN), which can be loaded with...

2010-08-16 12:35:00

ORANGE COUNTY, Calif., Aug. 16 /PRNewswire/ -- NanoSmart(TM) Pharmaceuticals, Inc., a California corporation developing novel biopharmaceuticals, is pleased to report that it has received a Notice of Allowance for a US patent on its proprietary cancer tumor targeting technology. "We have taken an approach to targeting tumors that is different from other companies," said Dr. Henry Smith, CEO of the company. "While most of cancer research has focused on developing antibodies to specific...


Word of the Day
malpais
  • The ragged surface of a lava-flow.
'Malpais' translates from Spanish as 'bad land.'